FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894578599> ?p ?o ?g. }

• W2894578599 endingPage "e7" @default.
• W2894578599 startingPage "e7" @default.
• W2894578599 abstract "Ovarian cancer is the 5th most common cancer in UK women with a high relapse rate. The overall survival for ovarian cancer has remained low for decades prompting a real need for new therapies. Recurrent ovarian cancer remains confined in the peritoneal cavity in >80% of the patients, providing an opportunity for locoregional administration of novel therapeutics, including gene and viral therapy approaches. Immunotherapy is an expanding field, and includes oncolytic viruses as well as monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines. Oncolytic viruses cause direct cancer cell cytolysis and immunogenic cell death and subsequent release of tumor antigens that will prime for a potent tumor-specific immunity. This effect may be further enhanced when the viruses are engineered to express, or coadministered with, immunostimulatory molecules. Currently, the most commonly used and well-characterized vectors utilized for virotherapy purposes are adenoviruses. They have been shown to work synergistically with traditional chemotherapy and radiotherapy and have met with success in clinical trials. However, pre-existing immunity and poor in vivo models limit our ability to fully investigate the potential of oncolytic adenovirus as effective immunotherapies which in turn fosters the need to develop alternative viral vectors. In this review we cover recent advances in adenovirus-based oncolytic therapies targeting ovarian cancer and recent advances in mapping immune responses to oncolytic virus therapies in ovarian cancer." @default.
• W2894578599 created "2018-10-12" @default.
• W2894578599 creator A5024135392 @default.
• W2894578599 creator A5054844851 @default.
• W2894578599 creator A5057327774 @default.
• W2894578599 date "2018-08-01" @default.
• W2894578599 modified "2023-09-26" @default.
• W2894578599 title "Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses" @default.
• W2894578599 cites W1484464171 @default.
• W2894578599 cites W1514279614 @default.
• W2894578599 cites W1525386479 @default.
• W2894578599 cites W1531166036 @default.
• W2894578599 cites W1563488686 @default.
• W2894578599 cites W1715272219 @default.
• W2894578599 cites W1817849244 @default.
• W2894578599 cites W1842419814 @default.
• W2894578599 cites W1847784260 @default.
• W2894578599 cites W1888836615 @default.
• W2894578599 cites W1913328895 @default.
• W2894578599 cites W1930835943 @default.
• W2894578599 cites W1963910714 @default.
• W2894578599 cites W1964730353 @default.
• W2894578599 cites W1965047367 @default.
• W2894578599 cites W1965497380 @default.
• W2894578599 cites W1970666372 @default.
• W2894578599 cites W1979980796 @default.
• W2894578599 cites W1982783404 @default.
• W2894578599 cites W1985517191 @default.
• W2894578599 cites W1991077572 @default.
• W2894578599 cites W1994325708 @default.
• W2894578599 cites W2005042183 @default.
• W2894578599 cites W2007952588 @default.
• W2894578599 cites W2008525376 @default.
• W2894578599 cites W2011912615 @default.
• W2894578599 cites W2013107316 @default.
• W2894578599 cites W2023310830 @default.
• W2894578599 cites W2024040080 @default.
• W2894578599 cites W2025243162 @default.
• W2894578599 cites W2028074588 @default.
• W2894578599 cites W2029893817 @default.
• W2894578599 cites W2036154310 @default.
• W2894578599 cites W2041243019 @default.
• W2894578599 cites W2041267103 @default.
• W2894578599 cites W2051758487 @default.
• W2894578599 cites W2055057323 @default.
• W2894578599 cites W2066671159 @default.
• W2894578599 cites W2067067209 @default.
• W2894578599 cites W2072067595 @default.
• W2894578599 cites W2073217923 @default.
• W2894578599 cites W2075711878 @default.
• W2894578599 cites W2080543048 @default.
• W2894578599 cites W2081577685 @default.
• W2894578599 cites W2087773557 @default.
• W2894578599 cites W2088046492 @default.
• W2894578599 cites W2090973422 @default.
• W2894578599 cites W2093059993 @default.
• W2894578599 cites W2094209778 @default.
• W2894578599 cites W2096232093 @default.
• W2894578599 cites W2102807955 @default.
• W2894578599 cites W2103803877 @default.
• W2894578599 cites W2105757240 @default.
• W2894578599 cites W2109274792 @default.
• W2894578599 cites W2111900617 @default.
• W2894578599 cites W2111954625 @default.
• W2894578599 cites W2116145684 @default.
• W2894578599 cites W2117845103 @default.
• W2894578599 cites W2118073850 @default.
• W2894578599 cites W2125681453 @default.
• W2894578599 cites W2125933228 @default.
• W2894578599 cites W2128780762 @default.
• W2894578599 cites W2130330160 @default.
• W2894578599 cites W2137074525 @default.
• W2894578599 cites W2142263069 @default.
• W2894578599 cites W2143113338 @default.
• W2894578599 cites W2147315970 @default.
• W2894578599 cites W2147649350 @default.
• W2894578599 cites W2149444911 @default.
• W2894578599 cites W2150291449 @default.
• W2894578599 cites W2150881149 @default.
• W2894578599 cites W2155884268 @default.
• W2894578599 cites W2156653943 @default.
• W2894578599 cites W2157644635 @default.
• W2894578599 cites W2158744232 @default.
• W2894578599 cites W2160874621 @default.
• W2894578599 cites W2162645859 @default.
• W2894578599 cites W2167451108 @default.
• W2894578599 cites W2170329311 @default.
• W2894578599 cites W2170739773 @default.
• W2894578599 cites W2177850317 @default.
• W2894578599 cites W2185596862 @default.
• W2894578599 cites W2233366168 @default.
• W2894578599 cites W2242902452 @default.
• W2894578599 cites W2253422769 @default.
• W2894578599 cites W2282447757 @default.
• W2894578599 cites W2299651777 @default.
• W2894578599 cites W2314704903 @default.
• W2894578599 cites W2318049754 @default.
• W2894578599 cites W2321875012 @default.

• next